Hologic’s (HOLX) GAI Program to Include Aptima SARS-CoV-2 Assay Posted byZacks Equity Research January 6, 2022 Leave a comment on Hologic’s (HOLX) GAI Program to Include Aptima SARS-CoV-2 Assay The addition of Aptima SARS-CoV-2 assay to Hologic’s (HOLX) Global Access Initiative is likely to improve its accessibility.